IL1B and neoplasm: This functional impairment of Tregs was further linked to an enhanced TH17 cell response, marked by increased secretion of IL‐1β, which aligns with the study's hypothesis that reducing Treg‐mediated suppression could invigorate anti‐tumor immunity [55, 67].